Croatia’s PharmaS to Make Generic Drugs in Serbia, Novosti Says

PharmaS d.o.o., a Croatian pharmaceutical company, plans an 11 million-euro ($14.6 million) plant in northeastern Serbia, Vecernje Novosti newspaper reported, citing an unidentified person at PharmaS’ Serbian unit.

The plant in Zrenjanin will open by mid-2012, producing generic cardiovascular and gastrointestinal medications, according to the report.

To contact the reporter on this story: Misha Savic in Belgrade at msavic2@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.